Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | S27 - Innovations in Neuro-oncology

Wednesday 04/06/22
01:00 PM - 03:00 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Neuro-oncology
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:12 PM PDT Speaker 2022 Neuro-oncology Scientific Award: This award recognizes an individual from any discipline and of any academic rank for a singular scientific achievement that has advanced the field of neuro-oncology.
Elizabeth R. Gerstner, MD
01:00 PM - 01:00 PM PDT Speaker Walk-in Slides
Elizabeth R. Gerstner, MD
01:12 PM - 01:24 PM PDT Abstract 002 - Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
Scott R. Plotkin, MD, PhD, FAAN
01:24 PM - 01:36 PM PDT Abstract 003 - Revised diagnostic criteria and nomenclature for neurofibromatosis 2 and schwannomatosis: an international consensus recommendation
Scott R. Plotkin, MD, PhD, FAAN
01:36 PM - 01:48 PM PDT Abstract 004 - Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid
Wei Gu, MD,PhD
01:48 PM - 02:00 PM PDT Abstract 005 - Leptomeningeal Disease in Patients with Histone-Mutant Gliomas
Maria Diaz Ordonez, MD
02:00 PM - 02:12 PM PDT Abstract 006 - Caregiver Distress and Burden Over Time in Newly Diagnosed Gliomas
Lauryn Hemminger
02:12 PM - 02:24 PM PDT Abstract 007 - Clinical and Molecular Determinants of Survival Outcomes in Glioblastoma Patients Treated with Immune Checkpoint Inhibitors
Pushan Richard Dasgupta, MD, PhD
02:24 PM - 02:36 PM PDT Abstract 008 - Long-term survival and cognitive function follow up of primary CNS lymphoma treated with R-MVP followed by high dose chemotherapy with autologous stem cell transplant consolidation
Kate Elizabeth Therkelsen, MD
02:36 PM - 02:48 PM PDT Abstract 009 - CAR-T Cell Therapy in Recurrent Primary CNS Lymphoma (PCNSL): A Phase 2 Clinical Trial
Jorg Dietrich, MD, PhD, FAAN
02:48 PM - 03:00 PM PDT Abstract 010 - Clinical and Pathologic Determinants of Outcome for Non-Optic Pathway Gliomas in Adults with Neurofibromatosis Type 1
Anna Piotrowski, MD
Faculty Disclosures
Tracy T. Batchelor, MD, MPH Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Bruce A. C. Cree, MD, PhD, MCR, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. Dr. Cree has received publishing royalties from a publication relating to health care.
Scott R. Plotkin, MD, PhD, FAAN Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
John F. De Groot, MD An immediate family member of Dr. De Groot has received personal compensation for serving as an employee of Ziopharm Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Deciphera Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for FivePrime Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Carthera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadmon. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Biomedical Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Taiho Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kairos Venture Investments. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Syneos Health. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Monteris. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Agios. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mundipharma Research. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GenomiCare. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Del Mar Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tocagen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioasis Technologies, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ResTORbio, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation Medicine, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novogen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Deciphera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insys Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lily. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella Clinical. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karyopharm Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiyatec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanquish Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orsenix, Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Global Services, LLC. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBL Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines, Inc.. An immediate family member of Dr. De Groot has received stock or an ownership interest from Ziopharm Oncology. An immediate family member of Dr. De Groot has received stock or an ownership interest from Gilead. The institution of Dr. De Groot has received research support from Carthera. The institution of Dr. De Groot has received research support from HaiHe Pharma. The institution of Dr. De Groot has received research support from Taiho Pharma.
Christian Grommes, MD Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grommes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curis. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono.
Nimish A. Mohile, MD, FAAN Dr. Mohile has nothing to disclose.
S. Andrew Josephson, MD, FAAN Dr. Josephson has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw Hill---Harrison's Online. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Josephson has received research support from NINDS. Dr. Josephson has received publishing royalties from a publication relating to health care. Dr. Josephson has received publishing royalties from a publication relating to health care.
Benzi Kluger, MD, FAAN The institution of Dr. Kluger has received research support from NIH. The institution of Dr. Kluger has received research support from PCORI.
Jaishri Blakeley, MD, FAAN Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics.
Joy Ellen Burke, MD No disclosure on file
Carlos Correia, MD No disclosure on file
Elizabeth R. Gerstner, MD Dr. Gerstner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Midatech. Dr. Gerstner has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Gerstner Family Foundation. The institution of Dr. Gerstner has received research support from NCI.
Vanja C. Douglas, MD Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Jorg Dietrich, MD, PhD, FAAN Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Elena Pentsova, MD The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc.
Pierre Wolkenstein Pierre Wolkenstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Pierre Wolkenstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks.
Michael R. Wilson, MD, FAAN Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from UCSF Weill Institute for Neurosciences. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice.
Alexandra M. Miller, MD Dr. Miller has nothing to disclose.
Jeffrey Marc Gelfand, MD, MAS, FAAN Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant and Expert, Vaccine Injury Compensation Program with United States Health and Human Services and Department of Justice. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Andreas Rauschecker Mr. Rauschecker has nothing to disclose.
Justin T. Jordan, MD, MPH, FAAN Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Dietitians on Demand. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Harborlight Montesorri. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Navio Theragnostics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Recursion Pharmaceuticals, Inc. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CEC Oncology. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Texas Health Resources. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Children's Tumor Foundation. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BCD Meetings. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michigan State University. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akeila Bio. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has stock in Navio Theragnostics. Dr. Jordan has stock in The Doctor Lounge. An immediate family member of Dr. Jordan has stock in OldGate. Dr. Jordan has stock in Akeila Bio. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Reimbursement for potential consultant role that was aborted with Magnet Biomedicine. Dr. Jordan has a non-compensated relationship as a board member with United Council for Neurologic Subspecialties that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a board member with Neurofibromatosis Northeast that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a board member with ABA Academy that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a chair, scientific advisory board and board member with Neurofibromatosis Network that is relevant to AAN interests or activities.
Roy E. Strowd, III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Denise Leung, MD, MS Dr. Leung has stock in Enzo Ventures (real estate). An immediate family member of Dr. Leung has stock in Enzo Ventures (real estate). The institution of Dr. Leung has received research support from NCCN/Pfizer.
Deborah A. Forst, MD Dr. Forst has stock in Eli Lilly. Dr. Forst has received research support from Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Forst has received research support from Palliative Care Research Cooperative Group. Dr. Forst has received research support from American Cancer Society Institutional Research Grant.
Maulik Shah, MD Dr. Shah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Football League.
Andrew L. Lin, MD The institution of Dr. Lin has received research support from Bristol Myers Squibb. The institution of Dr. Lin has received research support from NantOmics. The institution of Dr. Lin has received research support from Society of Memorial Sloan Kettering Cancer Center.
Jennifer N. Serventi, PA Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Carl Aaron Gold, MD Dr. Gold has received personal compensation for serving as an employee of Stanford University. An immediate family member of Dr. Gold has received personal compensation for serving as an employee of Stanford University.
Anna Piotrowski, MD Dr. Piotrowski has nothing to disclose.
Megan Richie, MD Dr. Richie has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology.
Bardia Nourbakhsh, MD The institution of Dr. Nourbakhsh has received research support from Genentech. The institution of Dr. Nourbakhsh has received research support from national MS Society . The institution of Dr. Nourbakhsh has received research support from Department of Defense. The institution of Dr. Nourbakhsh has received research support from NIH.
Nazanin Koohbanani Majd, MD No disclosure on file
Rebecca M. Brown, MD, PhD Dr. Brown has nothing to disclose.
Tarik Tihan Tarik Tihan has nothing to disclose.
Ying Yuan Ying Yuan has received personal compensation for serving as an employee of MD Anderson Cancer Center . Ying Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Ying Yuan has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Servier. Ying Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boehringer Ingelheim. The institution of Ying Yuan has received research support from NCI. Ying Yuan has received publishing royalties from a publication relating to health care. Ying Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NCI.
Ingo K. Mellinghoff, MD, FACP Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Voyager Therapeutics . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Group. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Puma Biotechnology. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DC Europa Ltd. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardinal Health. Dr. Mellinghoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Mellinghoff has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO/JCO. The institution of Dr. Mellinghoff has received research support from Amgen. The institution of Dr. Mellinghoff has received research support from General Electric. The institution of Dr. Mellinghoff has received research support from Lilly. The institution of Dr. Mellinghoff has received research support from Kazia Therapeutics. An immediate family member of Dr. Mellinghoff has received research support from Vigeo Therapeutics. The institution of an immediate family member of Dr. Mellinghoff has received research support from Samus Therapeutics. The institution of Dr. Mellinghoff has received research support from Erasca .
Chinazom Uchenna Ibegbu, MD Dr. Ibegbu has nothing to disclose.
Gareth Evans Gareth Evans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Gareth Evans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks. Gareth Evans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Recursion.
Zaid Arif Soomro, MBBS Dr. Soomro has nothing to disclose.
Yi-Bin Chen Yi-Bin Chen, 13609 has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Incyte. Yi-Bin Chen, 13609 has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi. Yi-Bin Chen, 13609 has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Yi-Bin Chen, 13609 has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Equilium. Yi-Bin Chen, 13609 has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actinium. Yi-Bin Chen, 13609 has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celularity.
Hannah Sample, 14202 Hannah Sample, 14202 has nothing to disclose.
Maria Diaz Ordonez, MD Dr. Diaz Ordonez has nothing to disclose.
Kate Elizabeth Therkelsen, MD Dr. Therkelsen has nothing to disclose.
Lauryn Hemminger Dr. Hemminger has nothing to disclose.
Fausto Rodriguez Fausto Rodriguez has nothing to disclose.
Kristin Alfaro-Munoz Kristin Alfaro-Munoz has nothing to disclose.
Jian Campion Jian Campion has nothing to disclose.
Kelsey Zorn The institution of Kelsey Zorn has received research support from Chan Zuckerberg Initiative. The institution of Kelsey Zorn has received research support from Sandler Foundation. The institution of Kelsey Zorn has received research support from William K. Bowes, Jr Foundation. The institution of Kelsey Zorn has received research support from National Institutes of Health.
Steve Miller, MD Steve Miller, MD has nothing to disclose.
Matthew Frigault No disclosure on file
Marcela Maus Marcela Maus has received personal compensation in the range of $0-$499 for serving as a Consultant for Adapt immune, Agenus, Arcellx, Astellas, AstraZeneca, Atara, Bayer, BMS, Cabaletta Bio(SAB), CRISPR therapeutics, In8bio (SAB), Intellia, GSK, Kite Pharma, Micromedicine, Novartis, Sanofi, TCR2 (SAB), Tmunity, Torque, and WindMIL . Marcela Maus has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for 2Seventy Bio. Marcela Maus has received stock or an ownership interest from Century Therapeutics, TCR2, 2SeventyBio. The institution of Marcela Maus has received research support from CRISPR therapeutics, Kite Pharma, Servier, Novartis. Marcela Maus has received intellectual property interests from a discovery or technology relating to health care.
Jessica Faith Occhiogrosso Ms. Occhiogrosso has nothing to disclose.
Pushan Richard Dasgupta, MD, PhD Dr. Dasgupta has nothing to disclose.
Carlos Ramos No disclosure on file
Charles Bornstein Charles Bornstein has nothing to disclose.
Tejus Bale Tejus Bale has nothing to disclose.
Wei Gu, MD,PhD The institution of Prof. Gu has received research support from NIH. The institution of Prof. Gu has received research support from Burroughs Wellcome.
Scot Federman Mr. Federman has nothing to disclose.
Linlin Wang, MD,PhD Dr. Wang has received personal compensation for serving as an employee of UCSF.
Shaun Arevalo Mr. Arevalo has nothing to disclose.
Eric Nguyen, MD,PhD Dr. Nguyen has received stock or an ownership interest from Moderna, Inc..
Eric Talevich, PhD Dr. Talevich has received personal compensation for serving as an employee of Karius, Inc. Dr. Talevich has received personal compensation for serving as an employee of DNAnexus, Inc..
Elaine Hsu Ms. Hsu has nothing to disclose.
Sonika Dahiya, MD Dr. Dahiya has nothing to disclose.
Kevin Arthur Lindell, Jr. Mr. Lindell has nothing to disclose.
Yasemin Sucu Miss Sucu has nothing to disclose.
Michael Andrew Trailor, Other Mr. Trailor has nothing to disclose.
Heather Lin, PhD Dr. Lin has nothing to disclose.
Kathleen Mary Ellen Gallagher, PhD Dr. Gallagher has nothing to disclose.
Patrice Susan Pancza, Other Ms. Pancza has received personal compensation for serving as an employee of Children's Tumor Foundation.
Laura Prichett, PhD Dr. Prichett has nothing to disclose.
Eric Legius, MD,PhD Prof. Legius has received personal compensation in the range of $500-$4,999 for serving as a speaker internal Astra-Zeneca Webinar with Astra-Zeneca. Prof. Legius has a non-compensated relationship as a advisor for health care introduction of Koselugo with University of Leuven that is relevant to AAN interests or activities.
Jose Diarte, MPH Mr. Diarte has nothing to disclose.
Daniella Cook, Other Miss Cook has nothing to disclose.
Gabriel DePinho, Other Mr. DePinho has nothing to disclose.
Susan Huson No disclosure on file
Ludwine Messiaen No disclosure on file